Advancing Remote Glucose Monitoring for More Consistent Diabetes Care

ZHONGSHAN, China - Rezul -- As diabetes management continues to move beyond traditional care settings, consistent and reliable blood glucose monitoring has become increasingly important for healthcare providers working to improve outcomes and expand care delivery.

Transtek, a provider of connected health solutions, today announced continued progress in its diabetes monitoring portfolio, supporting more effective remote glucose monitoring across diverse patient populations.

Remote patient monitoring (RPM) is playing a growing role in chronic care management, particularly as healthcare providers focus on improving patient adherence, reducing missed readings, and maintaining better visibility into daily glucose patterns. However, practical challenges remain—especially among elderly patients, individuals with limited digital literacy, or those without access to smartphones or stable connectivity.

More on Rezul News

• Weeks After Michigan Debut, CENTURY 21 Circle Adds Second Office in Coldwater
• Brian D Chase Selected to the 2026 Nation's Top One Percent Personal Injury Lawyers
• Most Americans Choose Their Water Brand Because of Its Natural Source — Yet Fewer Than 3 in 10 Understand What Spring Water Actually Is
• Chris Blasczak Named North Shore's Premier AI-Powered Listing Real Estate Agent
• North Shore Real Estate Leader Turns AI Skeptic to AI Authority

To help address these challenges, Transtek offers connected blood glucose meters designed to simplify the monitoring experience. By combining 4G BGM with device solutions, patients can measure and transmit readings without relying on mobile applications or Wi-Fi setup. This approach reduces barriers to use, supports more consistent capture of readings, and enables healthcare providers to better understand glucose patterns over time, including key indicators such as time in range.

"Improving glucose monitoring isn't just about accuracy—it's about ensuring patients can consistently engage with the process in their daily lives," Transtek spokesperson said. "Simplifying the experience is essential to reducing missed readings and supporting more scalable RPM programs."

More on Rezul News

• Unlocking Multi-Sector Growth; Graphite Acquisition Powers EV Entry While Streamlined Consumer Snack Business Fuels Growth: (N A S D A Q: SOWG)
• Permian Museum Adds Carbonaceous Chondrite Reference Photos
• L2 Aviation Receives FAA STC and PMA for Klatt Works SAVED™ Smoke Vision System
• Axencis Launches Performance Partnership for Brand Protection
• CCHR Says New OIG Report Raises Concerns about Drugging Elderly with Antipsychotics

As part of its ongoing commitment to quality and reliability, the company also announced that its blood glucose test strips have recently received certification from the National Medical Products Administration (NMPA), reinforcing performance consistency in routine clinical use.

With a continued focus on usability, consistency, and scalable deployment, Transtek supports healthcare providers in building more effective diabetes management programs—helping bridge the gap between clinical objectives and real-world patient behavior.

About Transtek

Transtek provides remote patient monitoring devices and solutions designed to help healthcare providers manage chronic conditions more effectively. Its portfolio includes a range of monitoring devices and integrated services that support patient engagement, improve visibility into patient status, and enable scalable remote care.